Core Viewpoint - The term "DeepSeek moment" is emerging as a topic in global stock markets, symbolizing the disruption of global industry structures and mainstream technologies by innovations originating from China, particularly in the AI and biopharmaceutical sectors [1][3]. Group 1: AI Industry - In January, the Chinese emerging enterprise DeepSeek launched a low-cost generative AI, challenging the United States' dominance in the AI sector [1]. - The "DeepSeek moment" reflects a significant shift in technological leadership from the U.S. to China, indicating a potential change in global power dynamics [1]. Group 2: Biopharmaceutical Industry - Following the AI sector, the biopharmaceutical industry is experiencing its own "DeepSeek moment," highlighted by Pfizer's exclusive licensing agreement with China's 3SBio for cancer treatment drug development and production [3]. - After the announcement, 3SBio's stock surged by 70% compared to the end of April, showcasing investor confidence in Chinese biopharmaceutical companies [3]. - Since the end of 2024, the stock index of biotechnology companies listed in Hong Kong has increased by 51%, significantly outperforming the Hang Seng Index (17%) and the S&P 500 Index (1%), indicating high investor expectations for Chinese biotech firms [3].

Core Insights - The article discusses the concept of "Sputnik Moment" in various sectors, particularly focusing on the need for a similar moment in Chinese consumer confidence, which has been lacking despite advancements in other industries [1][14]. Group 1: Biotechnology and Pharmaceuticals - CanSino Biologics' PD-1/VEGF dual antibody "Yivolumab" achieved a significant milestone by outperforming the global leader "K drug" in clinical trials, marking a leading position for China in the dual antibody sector [5]. - The proportion of large pharmaceutical companies engaging in significant transactions with Chinese biotech firms has surged from less than 5% before 2019 to 31% in 2024, indicating a growing recognition of China's biotech capabilities [6]. Group 2: Aerospace and Defense - China successfully conducted test flights of two sixth-generation fighter jets on December 26, 2024, marking a significant breakthrough in global aviation technology and establishing China as the first country to achieve this feat [7][8]. - The successful test flights signify a new phase in the competition for air combat dominance, with advanced features such as all-aspect stealth and AI integration [7][8]. Group 3: Artificial Intelligence - DeepSeek's R1 model achieved performance comparable to OpenAI's GPT-3 at a fraction of the training cost, leading to a significant drop in Nvidia's stock price and highlighting a pivotal moment in the AI sector [9]. - The advancements in AI technology from Chinese companies are prompting a reevaluation of strategies in the U.S. tech landscape, as noted by prominent venture capitalists [9]. Group 4: Automotive Industry - In 2024, China exported nearly 6 million vehicles, significantly outpacing Japan's 4 million, with BYD emerging as the largest brand for pure electric vehicles globally [10][11]. - The automotive sector is undergoing rapid changes, with Chinese brands like BYD and Geely ranking among the top ten global automotive brands, reflecting a shift in market dynamics [11]. Group 5: Consumer Confidence and Economic Challenges - Consumer confidence in China has been declining, with significant increases in household savings and deflationary pressures observed [3][14]. - The decline in consumer confidence can be traced back to several factors, including geopolitical tensions, the real estate crisis, and the impact of COVID-19 lockdowns [15][18][20]. - The article emphasizes the need for measures to stabilize the real estate market and enhance consumer confidence to stimulate domestic consumption [24][25].